Vascular access site occlusion: Which Medications Cause It? (72 Reports Across 7 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Vascular access site occlusion has been reported as an adverse event with 7 different drugs in the FDA's FAERS database, with 72 total reports. 4 of these reports resulted in death.The drugs most commonly associated with Vascular access site occlusion are REMIMAZOLAM, PANTOPRAZOLE, and ATORVASTATIN.
72
Total Reports
7
Drugs Involved
4
Deaths
20
Hospitalizations
46.6 yrs
Average Patient Age
51.2% / 48.8%
Female / Male
Which Drugs Cause Vascular access site occlusion Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| REMIMAZOLAM | 11 | 8.0% | 0 | 0 | 0 |
| PANTOPRAZOLE | 9 | 0.0% | 0 | 8 | 0 |
| ATORVASTATIN | 8 | 0.0% | 0 | 8 | 0 |
| METOPROLOL | 8 | 0.0% | 0 | 8 | 0 |
| OXALIPLATIN | 8 | 0.0% | 0 | 8 | 0 |
| RAMIPRIL | 8 | 0.0% | 0 | 8 | 0 |
| CARFILZOMIB | 6 | 0.0% | 0 | 0 | 0 |